secwatch / observer
8-K filed March 19, 2024, 7:59 PM ET ticker SYBX CIK 0001527599
earnings confidence high sentiment negative materiality 0.85

Synlogic discontinues PKU program; Q4 net loss $14.5M, cash $47.7M

SYNLOGIC, INC.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SYNLOGIC, INC. reported the year ended December 31, 2023 results: revenue $3.4 million, net income $57.3 million, EPS $8.81 per share.

Period
the year ended December 31, 2023
Revenue
$3.4 million
Net income
$57.3 million
EPS
$8.81 per share
Result
reported results
Exact text from the filing
$1.71 per share, compared to a consolidated net loss of $16.7 million, or $3.54 per share, for the corresponding period in 2022. Full Year 2023 Financial Results Revenues were $3.4 million for the year ended December 31, 2023, compared to $1.2 million for the same period in 2022. Revenue in both periods was associated with the research collaboration with Roche.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SYNLOGIC, INC. reported the quarter ended December 31, 2023 results: revenue $2.8 million, net income $14.5 million, EPS $1.71 per share.

Period
the quarter ended December 31, 2023
Revenue
$2.8 million
Net income
$14.5 million
EPS
$1.71 per share
Result
reported results
Exact text from the filing
Company. Fourth Quarter 2023 Financial Results As of December 31, 2023, Synlogic had cash, cash equivalents, and short-term marketable securities of $47.7 million. Revenue was $2.8 million for the three months ended December 31, 2023, compared to $0.1 million for the corresponding period in 2022. Revenue in both periods was associated with the research
View on SEC.gov

1047 earnings releases filed in the last 30 days. Browse all earnings releases →

SYNLOGIC, INC. filing history →

Source: SEC EDGAR
accession 0000950170-24-033145
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.